A review of major Crohn’s disease susceptibility genes and their role in disease pathogenesis

다국어 초록 (Multilingual Abstract)

Crohn’s disease (CD) is a chronic inflammatory bowel disease whose relevance is increasing in industrialized society. Recent genome wide association studies revealed over seventy one loci associated with disease penetrance. Several variants that increase disease risk encode for altered proteins that diminish bacterial host defense. NOD2 alters intracellular bacterial sensing while ATG16L1 is thought to diminish bacterial clearance by impairing autophagy. Additionally, changes in the IBD5locus are thought to diminish barrier function. Alternatively,recent data indicate a gain of function genetic variant of IL23R is protective amongst European CD patients. These recent genetic discoveries contradict historical theories that Crohn’s disease results from overactive auto-aggressive responses. Rather,new genetic data suggest disease-associated variants encode for dysfunctional proteins that diminish essential innate immune responses against commensal organisms. This review provides an overview of these critical discoveries and places them in their biological context.

참고문헌 (Reference)

• 1 Glas J, "rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants" 2 : 819-, 2007
• 2 Cadwell K, "Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine" 141 : 1135-1145, 2010
• 3 Xavier RJ, "Unravelling the pathogenesis of inflammatory bowel disease" 448 : 427-434, 2007
• 4 Tysk C, "Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins; A study of heritability and the influence of smoking" 29 : 990-996, 1988
• 5 Hradsky O, "Two Independent Genetic Factors Responsible for the Associations of the IBD5 Locus with Crohn’s Disease in the Czech Population" 1-7, 2010
• 6 Lecat A, "The protein NOD2: an innate receptor more complex than previously assumed" 80 : 2021-2031, 2010
• 7 Nell S, "The impact of the microbiota on the pathogenesis of IBD" 8 : 564-577, 2010
• 8 Karlinger K, "The epidemiology and the pathogenesis of inflammatory bowel disease" 35 : 154-167, 2000
• 9 Matzinger P, "The danger model: a renewed sense of self" 296 : 301-305, 2002
• 10 Kim Y, "The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands" 28 : 246-257, 2008
• 11 Noble CL, "The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn’s disease" 129 : 1854-1864, 2005
• 12 Ramsay RR, "The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions" 28 : 182-186, 2000
• 13 Van Limbergen, J, "The Genetics of Crohn’s Disease" 10 : 89-116, 2009
• 14 Glas J, "The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population" 103 : 682-691, 2008
• 15 Swoger JM, "Supportive therapy in IBD: what additional diagnoses and conditions must be treated" 28 : 452-462, 2010
• 16 Burckhardt G, "Structure of renal organic anion and cation transporters" 278 : 853-866, 2000
• 17 Reinhard C, "Role of the IBD5 Susceptibility Locus in the Inflammatory Bowel Diseases" 12 : 227-238, 2006
• 18 Cotterill L, "Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease" 24 : 297-302, 2010
• 19 Silverberg M, "Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn’s disease" 15 : 328-335, 2007
• 20 Fedorak RN, "Probiotics in the treatment of human inflammatory bowel diseases" 42 : 97-103, 2008
• 21 Lichtenstein GR, "Practice Parameters Committee of the American college of gastroenterology" 104 : 465-483, 2009
• 22 Travassos LH, "Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry" 11 : 55-62, 2010
• 23 Matthew C, "New links to the pathogenesis of Crohn disease provided by genome-wide association scans" 9 : 9-14, 2008
• 24 Hamm CM, "NOD2 status and human ileal gene expression" 16 : 1649-1657, 2010
• 25 Elson CO, "Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice" 132 : 2359-2370, 2007
• 26 Church J, "Molecular Genetics and Crohn's Disease. Surgical Clinics of North America 81"
• 27 Roediger W, "Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation" 67 : 773-782, 1986
• 28 Hugot J, "Lessons to be learned from the NOD2 gene in Crohn’s Disease" 15 : 593-597, 2003
• 29 Maynard CL, "Intestinal effector T cells in health and disease" 31 : 389-400, 2009
• 30 Hue S, "Interleukin-23 drives innate and T cell-mediated intestinal inflammation" 203 : 2473-2483, 2006
• 31 Csöngei V, "Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients" 16 : 176-183, 2010
• 32 van Heel DA, "Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs" 13 : 763-770, 2004
• 33 Podolsky DK, "Inflammatory bowel disease" 347 : 417-429, 2002
• 34 Kuballa P, "Impaired autophagy of an intracellular pathogen induced by a Crohn’s disease associated ATG16L1 variant" 3 : 3391-, 2008
• 35 Einarsdottir E, "IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease" 10 : 8-, 2009
• 36 Taylor KD, "IL23R haplotypes provide a large population attributable risk for Crohn's disease" 14 : 1185-1191, 2008
• 37 Kobayashi T, "IL23 differentially regulates, the TH1/TH17 balance in ulcerative colitis and Crohn’s disease" 57 : 1682-1689, 2008
• 38 Kullberg MC, "IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis" 203 : 2485-2494, 2006
• 39 Singh SB, "Human IRGM induces autophagy to eliminate intracellular mycobacteria" 313 : 1438-1441, 2006
• 40 Hildebrandt MA, "High-fat diet determines the composition of the murine gut microbiome independently of obesit" 137 : 1716-1724, 2009
• 41 Rioux JD, "Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci" 66 : 1863-1870, 2000
• 42 Franke A, "Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci" 42 : 1118-1125, 2010
• 43 Lee JC, "Genome-wide association studies and Crohn’s disease" 10 : 71-76, 2011
• 44 Barrett JC, "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease" 40 : 955-962, 2008
• 45 Duerr R, "Genome-Wide Association Studies Herald a New Era of Rapid Discoveries in Inflammatory Bowel Disease Research" 132 : 2045-2062, 2007
• 46 Newman WG, "Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population" 43 : 444-447, 2009
• 47 Fisher SA, "Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease" 40 : 710-712, 2008
• 48 McGovern D, "Genetic Epitasis of IL23/IL17 Pathway Genes in Crohn’s Disease" 15 : 883-889, 2009
• 49 Peltekova VD, "Functional variants of OCTN cation transporter genes are associated with Crohn disease" 36 : 471-475, 2004
• 50 Hu C, "Functional characterization of the NF-kappaB binding site in the human NOD2 promoter" 7 : 288-295, 2010
• 51 Molodecky NA, "Environmental risk factors for inflammatory bowel disease" 6 : 339-346, 2010
• 52 Berg DJ, "Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses" 98 : 1010-1020, 1996
• 53 Levine,B, "Eating oneself and Univited Guests: Autophagy-Related Pathways in Cellular Defense" 120 : 159-162, 2005
• 54 Eckburg PB, "Diversity of the human intestinal microbial flora" 308 : 1635-1638, 2005
• 55 Wang, K, "Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease" 84 : 399-405, 2009
• 56 Fujita N, "Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts" 284 : 32602-32609, 2009
• 57 Uhlig HH, "Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology" 25 : 309-318, 2006
• 58 Mizoguchi A, "Dependence of intestinal granuloma formation on unique myeloid DC-like cells" 117 : 605-615, 2007
• 59 McCarroll SA, "Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease" 40 : 1107-1112, 2008
• 60 Xavier R, "Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease" 4 : 1107-1112, 2008
• 61 Fernando MM, "Defining the role of the MHC in autoimmunity: a review and pooled analysis" 4 : e1000024-, 2008
• 62 Fritz T, "Crohn’s disease: NOD2, autophagy and ER stress converge" 2011
• 63 Brand S, "Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease" 58 : 1152-1167, 2009
• 64 Cadwell K, "Crohn's Disease Susceptibility Gene Interactions, a NOD to the Newcomer ATG16L1" 139 : 1448-1450, 2010
• 65 Stappenbeck T, "Crohn Disease: A current Perspective on Genetics, Autophagy and Immunity" 7 : 1-20, 2010
• 66 Zenhzhirong C, "Contribution of rs11465788 in IL23R gene to Crohn’s disease susceptibility and phenotype in Chinese population" 88 : 191-196, 2009
• 67 Xavier R, "Commensal flora: wolf in sheep's clothing" 128 : 1122-1126, 2005
• 68 Loftus EV Jr, "Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences" 126 : 1504-1517, 2004
• 69 Repnik K, "CTLA3 CT60 Single-Nucleotide Polymorphism is Associated with Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of CTLA4 Isoforms" 1-8, 2010
• 70 Deretic V, "Autophagy gives a nod and a wink to the inflammasome and Paneth cells in Crohn's disease" 15 : 641-642, 2008
• 71 Van Limbergen J, "Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe" 14 : 338-346, 2008
• 72 Beutler B, "Autoimmunity and Apoptosis: the Crohn’s connection" 15 : 5-14, 2001
• 73 Lacher M, "Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children" 99 : 727-733, 2010
• 74 Kosovac K, "Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients" 16 : 1311-1321, 2010
• 75 Hugot J, "Association of NOD2 leucine rich repeat variants with susceptibility to Crohn’s Disease" 411 : 599-603, 2001
• 76 Hugot J, "Association of NOD2 leucine rich repeat variants with susceptibility to Crohn’s Disease" 411 : 599-603, 2009
• 77 Palomino-Morales, RJ, "Association of ATG16L1 and IRGM genes polymorphisms withinflammatory bowel disease: a meta-analysis approach" 10 : 356-364, 2009
• 78 Mitozugchi A, "Animal Models of IBD: Linkage to human disease" 10 : 578-587, 2010
• 79 Fransen K, "Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn’s disease" 19 : 3482-3488, 2010
• 80 Tokuhiro S, "An Intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis" 35 : 341-348, 2003
• 81 Sabbah A, "Activation of innate immune antiviral responses by Nod2" 10 : 1073-1080, 2009
• 82 Lakatos P, "ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients" 40 : 867-873, 2008
• 83 Cadwell K, "A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells" 456 : 259-263, 2008
• 84 Hampe J, "A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn’s disease in ATG16L1" 39 : 207-211, 2007
• 85 Ogura Y, "A frameshift mutation in NOD2 association with susceptibility to Crohn’s disease" 411 : 599-603, 2001
• 86 Cadwell K, "A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn’s disease" 5 : 250-252, 2009
• 87 Duerr R, "A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene" 314 : 1461-1463, 2006
• 88 Noguchi E, "A CD associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1" 10 : 471-479, 2009